For Deaf Astronomer John Goodricke, The Sky Was No Limit [Forbes]
Danaher Corporation (DHR)
Last danaher corporation earnings: 1/30 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investors.danaher.com
Company Research
Source: Forbes
This portrait of Goodricke was painted shortly before his death. James Scouler, 1785 September 17 marks the 254th birthday of astronomer John Goodricke, whose brief career laid the groundwork for much of what we know today about variable stars. Like far too many children of his era, Goodricke fell seriously ill as a young boy. We'll never know for sure which illness caused the fever that left him deaf by the age of six; it could have been measles, mumps, or a potentially lethal respiratory infection called whooping cough or pertussis (all three of which can now be prevented by common vaccines), but another likely candidate is scarlet fever, caused by a particular group of streptococcus bacteria. He survived the fever -- likely thanks to a combination of luck and his parents' ability to afford medical care; Goodricke's father was a British diplomat, and his grandfather a baronet who held a seat in Parliament and a position on King George III's Privy Council.
Show less
Read more
Impact Snapshot
Event Time:
DHR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DHR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DHR alerts
High impacting Danaher Corporation news events
Weekly update
A roundup of the hottest topics
DHR
News
- Top Stock Reports for Danaher, Regeneron Pharmaceuticals & Palo Alto Networks [Yahoo! Finance]Yahoo! Finance
- Danaher Co. (NYSE: DHR) had its price target raised by analysts at Citigroup Inc. from $280.00 to $290.00. They now have a "buy" rating on the stock.MarketBeat
- Danaher Co. (NYSE: DHR) had its price target raised by analysts at TD Cowen from $280.00 to $290.00. They now have a "buy" rating on the stock.MarketBeat
- Danaher Co. (NYSE: DHR) had its price target raised by analysts at Bank of America Co. from $258.00 to $270.00. They now have a "neutral" rating on the stock.MarketBeat
- Danaher Co. (NYSE: DHR) had its price target raised by analysts at Barclays PLC from $260.00 to $270.00. They now have an "equal weight" rating on the stock.MarketBeat
DHR
Earnings
- 4/23/24 - Beat
DHR
Sec Filings
- 4/24/24 - Form 144
- 4/24/24 - Form 144
- 4/23/24 - Form IRANNOTICE
- DHR's page on the SEC website